Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Haematologica|December 20, 2011
Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioningJohanna Konopacki, Raphaël Porcher, Marie Robin, et al.
Blood|April 27, 2016
Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup studyJasmijn D E de Rooij, Riccardo Masetti, Marry M van den Heuvel-Eibrink, et al.
Blood|October 26, 2006
Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 studyAdrienne de Labarthe, Philippe Rousselot, Françoise Huguet-Rigal, et al.
Journal of Hematology & Oncology|May 4, 2021
Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALLMathieu Simonin, Aline Schmidt, Christophe Bontoux, et al.
Blood|April 17, 2015
Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemiaYves Chalandon, Xavier Thomas, Sandrine Hayette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trialsNicolas Boissel, Marie-Françoise Auclerc, Véronique Lhéritier, et al.
Leukemia Research|December 15, 2010
The addition of daunorubicin to imatinib mesylate in combination with cytarabine improves the response rate and the survival of patients with myeloid blast crisis chronic myelogenous leukemia (AFR01 study)Bénédicte Deau, Franck E Nicolini, Joelle Guilhot, et al.
Experimental Hematology|July 31, 2012
Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemiaAnna Kreutzman, Taina Jaatinen, Dario Greco, et al.
British Journal of Haematology|February 1, 2014
Clinical value of pre-transplant minimal residual disease in childhood lymphoblastic leukaemia: the results of the French minimal residual disease-guided protocolVirginie Gandemer, Cécile Pochon, Emmanuel Oger, et al.
Blood|March 22, 2024
Genomic imbalance analysis provides new insight into prognostic factors in adult and pediatric T-ALLEstelle Balducci, Mathieu Simonin, Nicolas Duployez, et al.
Pageof 11